$BMI

BADGER METER INC (BMI): Results of Operations and Financial Condition

BADGER METER INC (BMI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.PRESSRELEASE 2 bmi-ex99_pressrelease.htm EX-99.PRESSRELEASE EX-99.PressRelease Exhibit 99.1 Badger Meter News Release Dan Weltzien, Vice President – CFO and Treasurer investors@badgermeter.com BADGER METER REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS Milwaukee, WI, July 22

Original reporting
Published Jul 22, 2026, 12:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 22, 2026, 1:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BMI
Bearish
medium confidence
Mentioned
$BMI
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$BMIBearishMed
01

Why it matters

Traders can update expectations for Badger Meter’s 2026 revenue trajectory (ex-acquisitions flattish vs 2025) and margin outlook, while assessing whether AMI project phasing and integration progress translate into a stronger back-half run-rate.

02

Market read

The filing combines hard Q2 financials (sales, operating earnings, EPS, margins) with a directional full-year statement and acquisition integration update, which can drive near-term positioning into the earnings call.

03

What to watch

Base metrics exclude UDlive; investors may over-penalize GAAP declines without separating acquisition-related effects and intangible amortization, and should watch for order-rate and deployment commentary during the call.

Relevance 7/10Novelty 7/10Timing: ahead of/around the Q2 2026 earnings call today (July 22, 2026)

Background

This is an SEC 8-K with Exhibit 99.1 press release covering Badger Meter’s Q2 2026 results and outlook, including the May 1, 2026 acquisition of UDlive Limited.

Company-level read

Ticker impact

$BMIBearishMedium confidence
Context

Badger Meter reported Q2 2026 sales of $222.3M, EPS $1.02, and said full-year revenue ex-acquisitions is flattish versus 2025.

Expected impact

Near-term bias likely negative or cautious until investors gain confidence in the back-half revenue run-rate improvement and AMI deployment phasing.

Evidence & confidence

The filing provides concrete GAAP and non-GAAP datapoints (sales, operating earnings, margins, EPS) plus a specific full-year directional outlook (flattish ex-acquisitions) and integration progress on UDlive, which can drive repricing versus prior expectations.

Market effects

Water metering and smart-water software demand appears uneven, with AMI project phasing cited as a key driver; could influence sentiment toward utility infrastructure tech names.

No specific regional demand shock disclosed; commentary is framed as global water-sector digital transformation.

Integration of UDlive and sewer line monitoring expansion may be read across to municipal infrastructure modernization budgets globally.

Counterpoint

The sequential sales step-up and “awarded projects beginning to proceed into deployment” could outweigh the year-over-year declines if investors focus on back-half ramp rather than the first-half pacing.

Key entities

  • Badger Meter, Inc.

    NYSE-listed water technology provider reporting Q2 2026 results and a flattish ex-acquisition full-year revenue outlook.

  • UDlive Limited

    Acquired effective May 1, 2026, contributing two months of results and expanding sewer line monitoring capabilities.

Related articles

$VIAVMed

Inspection Instruments Stocks Q2 Earnings Review: Keysight (NYSE:KEYS) Shines

Viavi Solutions (down 10.9%) had the fastest revenue growth among inspection instruments stocks, while Badger Meter (NYSE:BMI, down 9.3%) reported a 6.6% revenue decline. Itron (NASDAQ:ITRI, up 12.2%) missed revenue estimates but exceeded EBITDA and EPS guidance. Teledyne (NYSE:TDY, down 3.7%) reported a 9.8% revenue increase, beating expectations. Market risks have shifted from AI to geopolitics and back to fundamentals.

$BMIMed

Why Badger Meter Stock Is Plummeting 18% Lower This Week

Badger Meter (BMI) shares fell about 18% for the week after the company reported mixed Q2 results on Wednesday. Sales declined 7% and EPS fell 13%, slightly above Wall Street’s low expectations. The stock dropped despite the beat, as guidance for 2026 called for only “flattish” sales growth in the second half.

$BMIMed

Badger Meter (NYSE: BMI) sees lower sales, buys UDlive and steps up buybacks

Badger Meter (NYSE: BMI) reported lower sales for the quarter and six months ended June 30, 2026. Net sales fell to $222.3 million (-6.6%) and $424.6 million (-7.7%). Utility water declined while flow instrumentation rose. Net earnings dropped to $29.7 million ($1.02 EPS) for the quarter and $57.1 million ($1.95 EPS) for six months. In May 2026, it bought UDlive for $94.4 million plus up to $50 million earn-out and funded buybacks and dividends.

$BMIMed

Badger Meter (BMI) Q2 2026 Earnings Call Transcript

Badger Meter (BMI) reported Q2 2026 utility water sales down 8% year over year, or down 9% excluding an acquisition, though up 8% sequentially on an organic basis. Operating earnings fell 12% to margins of 17.7%. Diluted EPS was $1.02. Free cash flow was $21.9 million. The company repurchased 204,000 shares for $25.3 million and has about $90 million remaining on authorization.

$005930.KSMedAI 8/10

Key facts: Samsung Electronics (005930) 55% margin; Goldman Buy; fell

Samsung Electronics (005930) reported preliminary Q3 revenue of 195 trillion won and operating profit of 107.4 trillion won, resulting in a 55.1% operating margin. Goldman Sachs maintains a Buy rating, citing strengths in NAND flash and HBF technology. The stock fell 5%–10% mid-October due to market pressures. Chairman Jay Y. Lee received 11.16M shares valued at 2.6 trillion won. Samsung retained a 23% global smartphone market share in Q3 2026, despite a 3% YoY shipment decline.

$UNHHighAI 8/10

UnitedHealth vs. Johnson & Johnson: Which Stock Is the Better Buy After Q3 Earnings?

UnitedHealth (UNH) and Johnson & Johnson (JNJ) reported Q3 earnings, with UNH beating estimates and raising its full-year EPS outlook to $20.50. JNJ's earnings declined but revenue grew, with mixed performance across divisions. UNH trades at a lower forward P/E (19X) and offers a higher dividend yield (2.45%) than JNJ (23X, 2%). Analysts favor UNH for its earnings recovery and valuation.